Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Author:

Doki Yuichiro1,Ajani Jaffer A.1ORCID,Kato Ken1,Xu Jianming1,Wyrwicz Lucjan1,Motoyama Satoru1,Ogata Takashi1,Kawakami Hisato1,Hsu Chih-Hung1,Adenis Antoine1,El Hajbi Farid1,Di Bartolomeo Maria1,Braghiroli Maria I.1,Holtved Eva1,Ostoich Sandra A.1,Kim Hye R.1,Ueno Masaki1,Mansoor Wasat1,Yang Wen-Chi1,Liu Tianshu1,Bridgewater John1,Makino Tomoki1,Xynos Ioannis1,Liu Xuan1,Lei Ming1,Kondo Kaoru1,Patel Apurva1,Gricar Joseph1,Chau Ian1ORCID,Kitagawa Yuko1

Affiliation:

1. From Osaka University Graduate School of Medicine, Osaka (Y.D., T.M.), National Cancer Center Hospital (K. Kato), Toranomon Hospital (M.U.), and Keio University School of Medicine (Y.K.), Tokyo, Akita University Hospital, Akita (S.M.), Kanagawa Cancer Center, Kanagawa (T.O.), and Kindai University Faculty of Medicine, Osakasayama (H.K.) — all in Japan; University of Texas M.D. Anderson Cancer Center, Houston (J.A.A.); Fifth Medical Center, Chinese PLA General Hospital, Beijing (J.X.), and Zhongshan...

Funder

Bristol-Myers Squibb

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3